Poxvirus Vectors: Mammalian Cytoplasmic-Based Expression Systems
Reference48 articles.
1. Alexander, W. A., Moss, B. and Fuerst, T. R., 1991. Novel system for regulated high level expression in vaccinia virus. Vaccines 90:221. 2. Ashorn, P., Berger, E. A. and Moss, B., 1990. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of non-primate cells with human cells. J. Virol. 64:2149. 3. Barrett, N., Mitterer, A., Mundt, W., Eibl, J., Eibl, M., Gallo, R. C., Moss, B. and Dorner, F., 1989. Large-scale production and purification of a vaccinia recombinant-derived HIV-1 gpl60 and analysis of its immunogenicity. AIDS Res. Human Retroviruses. 5: 159. 4. Blancou, J., Kieny, M. P., Lathe, R., Lecocq, J. P., Pastoret, P. P., Soulebot, J. P. and Desmettre, P., 1986. Oral vaccination of the fox against rabies using a live recombinant vaccinia virus. Nature. 322:373. 5. Boyle, D. B. and Coupar, B. E. H., 1988. A dominant selectable marker for the construction of recombinant poxviruses. Gene. 65:123.
|
|